Trials / Completed
CompletedNCT06992505
Assessment of Macrophage Activation syndromE in STill's Disease in Italy
Assessment of Macrophage Activation syndromE in STill's Disease: Retrospective Chart Analysis of Patient hIstory, Symptom Resolution and TreAtment Characteristics in Italy (AMETISTA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Swedish Orphan Biovitrum · Industry
- Sex
- All
- Age
- 6 Months – 80 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of macrophage activation syndrome in Still's disease: retrospective chart analysis of patient history, symptom resolution and treatment characteristics in Italy
Detailed description
This is an observational, retrospective cohort study on the treatment utilization and outcomes of Macrophage Activation Syndrome (MAS) refractory to glucocorticoids (GC) in patients with Still's disease. The study will be conducted entirely through medical chart abstraction; all data will be taken from the patient's medical record, with no additional assessments. The study will be conducted in Italy.
Conditions
Timeline
- Start date
- 2025-06-06
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
- First posted
- 2025-05-28
- Last updated
- 2025-12-02
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06992505. Inclusion in this directory is not an endorsement.